Tokyo International Law Office

Corporate and M&A, Compliance & Investigations, Healthcare & Life Sciences

Mikiharu Mori is the co-founder and managing partner of TKI. Mikiharu has been named as a leading practitioner for M&A by Japanese and global media, including Nihon Keizai Shinbun, Weekly Economist, IFLR 1000, The Legal 500 Asia Pacific, Asian Legal Business (ALB) and asialaw. His major publications include "Cross-border M&A Contract Practice" (editor and co-author) (Chuo Keizai-sha, 2021) and "Tender Offer Practice by Transaction Type" (Chuo Keizai-sha, 2023).

Mikiharu speaks frequently on various topics, including cross-border M&A, corporate governance and related legal issues.  Mikiharu also serves as a Think! Expert (commentator) for Nihon Keizai Shimbun and his comments are frequently published and featured in major newspapers, magazines and TV news reports.

He also serves as an outside statutory auditor (kansayaku) of a Japanese company listed with the Prime Market of the Tokyo Stock Exchange, advisor to the International Affairs Working Group of Japan Pharmaceutical Industry Legal Affairs Association, and Executive Director of Law Alumni Association of the University of Tokyo. Mikiharu also has experience of serving as Chair of Special Investigation Committee for corporate governance and compliance matter and Chair of Special Committee for Tender Offer of Japanese listed companies.

Oct. 2004-Dec. 2015: Nagashima Ohno & Tsunematsu Sep. 2011-Jul. 2012: Shearman & Sterling LLP New York office Jan. 2016-Mar. 2019  Hibiya-Nakata (Partner from Jul. 2017) Apr. 2019 : Established Tokyo International Law Office

Japanese, English

Registered as JCAA panel arbitrator candidate (Sep. 2020)

Appointed as Statutory Auditor (External) of Mandom Corporation (Jun. 2021)

Chair of Special Committee of Daiho Corp. (Tender Offer) (Mar. 2022)

Appointed as Executive Director of Law Alumni Association of the Unct. 2023)

Chair of Special Investigation Committee of LUCKLAND Co., Ltd. (Feb. 2024)

Advisor to the International Affairs Working Group of Japan Pharmaceutical Industry Legal Affairs Association (Aug. 2024)

LL.B., The University of Tokyo (2002)

LL.M., Columbia Law School (2011)